OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Investigational drugs under development for the treatment of PTSD
Benjamin Ragen, Jordan Seidel, Christine Chollak, et al.
Expert Opinion on Investigational Drugs (2015) Vol. 24, Iss. 5, pp. 659-672
Closed Access | Times Cited: 32

Showing 1-25 of 32 citing articles:

Cannabidiol as a Potential Treatment for Anxiety Disorders
Esther Blessing, Maria M. Steenkamp, Jorge Manzanares, et al.
Neurotherapeutics (2015) Vol. 12, Iss. 4, pp. 825-836
Open Access | Times Cited: 588

Animal models of PTSD: a challenge to be met
Gal Richter‐Levin, Oliver Stork, Mathias V. Schmidt
Molecular Psychiatry (2018) Vol. 24, Iss. 8, pp. 1135-1156
Open Access | Times Cited: 183

Glutamate dysregulation and glutamatergic therapeutics for PTSD: Evidence from human studies
Lynnette A. Averill, Prerana Purohit, Christopher L. Averill, et al.
Neuroscience Letters (2016) Vol. 649, pp. 147-155
Open Access | Times Cited: 162

Treatment-refractory posttraumatic stress disorder (TRPTSD): a review and framework for the future
Ralph J. Koek, Holly N. Schwartz, Stephenie Scully, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2016) Vol. 70, pp. 170-218
Closed Access | Times Cited: 59

Cannabinoids as therapeutics for PTSD
Brenda Sbarski, Irit Akirav
Pharmacology & Therapeutics (2020) Vol. 211, pp. 107551-107551
Closed Access | Times Cited: 45

Analysis of Anxiety Disorders and Post-Traumatic Stress Disorders for Screening Anxiolytic Drugs and Linking Preclinical and Clinical Research
Anna Kozłowska, Wan-Jiun Ma, Bai‐Chuang Shyu, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 4, pp. 1414-1414
Open Access

Ginkgo Biloba as a niche theme cognitive enhancer agent, 1420 dokumen of Scopus database. A bibliometric study from 1988 to 2024
ARMAN YURISALDI SALEH, Dwi Arwandi Yogi Saputra, Riezky Valentina, et al.
F1000Research (2025) Vol. 14, pp. 275-275
Open Access

Anti-PTSD-like effects of albiflorin extracted from Radix paeoniae Alba
Zhi-Kun Qiu, Jia-Li He, Xu Liu, et al.
Journal of Ethnopharmacology (2016) Vol. 198, pp. 324-330
Closed Access | Times Cited: 27

Correlation between interferon γ and interleukin 6 with PTSD and resilience
Dagmar Bruenig, Divya Mehta, C. Phillip Morris, et al.
Psychiatry Research (2017) Vol. 260, pp. 193-198
Open Access | Times Cited: 23

Ketamine alleviates fear memory and spatial cognition deficits in a PTSD rat model via the BDNF signaling pathway of the hippocampus and amygdala
Yue Teng, JiaYao Niu, Yang Liu, et al.
Behavioural Brain Research (2023) Vol. 459, pp. 114792-114792
Open Access | Times Cited: 6

Central Neuropeptide Y Plays an Important Role in Mediating the Adaptation Mechanism Against Chronic Stress in Male Rats
Yang Yu, Reji Babygirija, Jun Zheng, et al.
Endocrinology (2018) Vol. 159, Iss. 3, pp. 1525-1536
Open Access | Times Cited: 17

7, 8-Dihydroxyflavone Protects an Endothelial Cell Line from H2O2 Damage
Bingxiang Wang, Qian Zhang, Ruyong Yao, et al.
PLoS ONE (2015) Vol. 10, Iss. 8, pp. e0135345-e0135345
Open Access | Times Cited: 16

Akute und posttraumatische Belastungsstörung
Hans‐Peter Kapfhammer
Springer eBooks (2017), pp. 1965-2040
Closed Access | Times Cited: 11

Oxytocin differentially modulates pavlovian cue and context fear acquisition
Juliana Cavalli, Michaela Ruttorf, Mario Rosero Pahi, et al.
Social Cognitive and Affective Neuroscience (2017) Vol. 12, Iss. 6, pp. 976-983
Open Access | Times Cited: 11

Updates on Pharmacological Treatment of Post-Traumatic Stress Disorder
Rishav Koirala, Erik Ganesh Iyer Søegaard, Suraj Bahadur Thapa
Journal of Nepal Medical Association (2017) Vol. 56, Iss. 206
Open Access | Times Cited: 9

Theranostic pharmacology in PTSD: Neurobiology and timing
Ralph J. Koek, Tinh N. Luong
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2018) Vol. 90, pp. 245-263
Closed Access | Times Cited: 8

7,8-Dihydroxyflavone protects neurons against oxygen-glucose deprivation induced apoptosis and activates the TrkB/Akt pathway
Qinxiang Zhou, Hao Tang, Dingqun Bai, et al.
PeerJ (2022) Vol. 10, pp. e12886-e12886
Open Access | Times Cited: 4

Pain, pleasure and placebo: the cannabinoids in reward processing and the perception of pain
Maximillian H. Brodermann
Mental Health and Addiction Research (2016) Vol. 1, Iss. 3
Open Access | Times Cited: 2

Foundations of Disaster Psychiatry
Robert J. Ursano, Robert J. Ursano, Robert J. Ursano
Cambridge University Press eBooks (2017), pp. 27-86
Closed Access | Times Cited: 2

Internal threats to police wellness
Christine C. Kwiatkowski, Alfred J. Robison
Elsevier eBooks (2020), pp. 29-36
Closed Access | Times Cited: 1

Oxytocin receptor variant rs53576 genotype is associated with dysphoric arousal symptoms of DSM-5 posttraumatic stress disorder in Chinese earthquake survivors
Chengqi Cao, Li Wang, Ruojiao Fang, et al.
Chinese Journal of Traumatology (2021) Vol. 24, Iss. 4, pp. 209-213
Open Access | Times Cited: 1

Akute und posttraumatische Belastungsstörung
Hans‐Peter Kapfhammer
Springer eBooks (2016), pp. 1-76
Closed Access

Page 1 - Next Page

Scroll to top